Ładuje się......
Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product
Farnesyl pyrophosphate synthase (FPPS) is an enzyme of the mevalonate pathway and a well-established therapeutic target. Recent research has focused around a newly identified druggable pocket near the enzyme's active site. Pharmacological exploitation of this pocket is deemed promising; however...
Zapisane w:
| Wydane w: | Nat Commun |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5253651/ https://ncbi.nlm.nih.gov/pubmed/28098152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms14132 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|